1st International Congress of Micro-Immunotherapy
The congress brings together scientists and health professionals on the theme "Immunomodulation and chronic diseases through the prism of autoimmunity: New concepts, new perspectives".
CERBA International participates as a sponsor and is present at a stand, sharing the latest advances in clinical analysis, to guide treatment with microimmunotherapy.
Microimmunotherapy is a modern immunomodulation therapy
It uses the same messengers as the immune system (cytokines, hormones, growth factors, nucleic acids) to transmit information to the body and "readjust" the immune response. Their main goal is to restore proper communication between immune cells, to help them regain their innate ability to defend themselves against aggressors (such as viruses, bacteria, fungi, toxins, or tumor cells) or limit their reaction when exaggerated.
Microimmunotherapy is a very effective therapeutic option in the treatment of diseases that present an imbalance of the immune system, both acute and chronic, such as viral, bacterial or parasitic infections, allergies, stress-related diseases and / or Aging processes, inflammatory processes, autoimmune diseases and cancer. It can be integrated into a therapeutic strategy adapted to the patient. In general, its characteristics make it well tolerated and compatible with other therapies.
1st International Congress of Micro-Immunotherapy. 18-20 de mayo 2017
Palacio de Congresos de Palma de Mallorca, España